← Open Payments lookup

BRIAN BORA: Open Payments

NPI 1891892600 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,901 in 119 payments from 12 companies in 2025. Trend: 2023 $2,860 · 2024 $3,819 · 2025 $3,901

Food & beverage: $3,895Education: $5
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.16$610
Janssen Pharmaceuticals, Inc15$578
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$470
ABBVIE INC.18$446
Axsome Therapeutics, Inc.8$362
E.R. Squibb & Sons, L.L.C.9$356
Alkermes, Inc.10$339
Neurocrine BioSciences, Inc.6$255
Otsuka America Pharmaceutical, Inc.9$189
Teva Pharmaceuticals USA, Inc.7$153

Products named: FANAPT, CAPLYTA, VRAYLAR, Auvelity, COBENFY, SPRAVATO, INGREZZA, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.